Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this study is to demonstrate that the combination of rituximab and chlorambucil is safe by examining the adverse event profile.
Critère d'inclusion
- CD20-positive B-cell chronic lymphocytic leukemia